Clinical Trial Detail

NCT ID NCT03189186
Title Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Irvine

renal cell carcinoma



Age Groups: adult senior

No variant requirements are available.